In summary, we propose a novel mechanism by which melatonin mediates upregulation of miR-504-3p, leading to transcriptional downregulation of p39 in hTau mice, modulating the phosphorylation of tau protein at CDK5-dependent phosphorylation sites in AD (Fig. 11). The gene discussed is MAPT; the disease is Alzheimer disease.